*001442188
*00520190521142208.0
*007ta
*008190110s2019    no a   e m    00  0 eng
*00901828nam a2200349 c 4500
*019  $bl
*020  $a9788283773583$qheftet
*035  $a(EXLNZ-47BIBSYS_NETWORK)999920726984702201
*035  $a(NO-LaBS)14863776(bibid)
*040  $aNO-OsNB$bnob$erda
*060 4$aWI 529
*08204$a616.99434706$223/nor$qNO-OsNB
*1001 $aBjørnelv, Gudrun Maria Waaler$d1984-$0(NO-TrBIB)1542227327992$4aut$_73144000
*24510$aHealth care utilization, costs, and benefits of treatments in metastatic colorectal cancer$cGudrun Maria Waaler Bjørnelv
*264 1$a[Oslo], Norway$bDepartment of Health Management and Health Economics, Institute of Health and Society, Faculty of Medicine, University of Oslo$c2019
*300  $a1 bind (varierende paginering)$billustrasjoner$c24 cm
*336  $atekst$2rdaco$0http://rdaregistry.info/termList/RDAContentType/1020
*337  $auformidlet$2rdamt$0http://rdaregistry.info/termList/RDAMediaType/1007
*338  $abind$2rdact$0http://rdaregistry.info/termList/RDACarrierType/1049
*4901 $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo
*500  $aDelvis opptrykk av artikler
*502  $aAvhandling (ph.d.) - Universitetet i Oslo, 2019
*650 2$aColorectal Neoplasms$xeconomics$0(DNLM)D015179Q000191$_73144100
*650 2$aColorectal Neoplasms$xpathology$0(DNLM)D015179Q000473$_61743500
*650 2$aHealth$xeconomics$0(DNLM)D006262Q000191$_18402000
*650 2$aPatient Acceptance of Health Care$xstatistics & numerical data$0(DNLM)D010342Q000706$_73144300
*7102 $aUniversitetet i Oslo$bDet medisinske fakultet$0(NO-TrBIB)90302138$4pbl$_10213300
*7102 $aUniversitetet i Oslo$bInstitutt for helse og samfunn$0(NO-TrBIB)15000757$4dgg$_11003700
*830  $aSeries of dissertations submitted to the Faculty of Medicine, University of Oslo$_10213500
*913  $aNorbok$bNB
*917  $ad
*999  $aoai:nb.bibsys.no:999919971494402202$b2021-11-14T20:21:06Z$z999919971494402202
^